Skip to main content
. 2022 Jun 24;13:894718. doi: 10.3389/fimmu.2022.894718

Table 3.

Clinicopathological parameters of patients.

Case id Age Gender Tumor size(cm) TNM Histological type Chemotherapy Radiotherapy
1 58 Female 1*1*1 T3N1M0 High-grade Serous IIIC Paclitaxel;
Lobaplatin
NA
2 53 Female 3*2.5*2.5 T3N1M1 High-grade Serous IVB Taxol; Carboplatin NA
3 68 Female 5*3*2.2 T3N1M0 High-grade Serous IIIC nab-paclitaxel, carboplatin NA
4 63 Female 15*13*13 T3N1M0 High-grade Serous IIIC Lobaplatin NA
5 65 Female 16.5*11.5*2.5 T3N1M0 High-grade Serous IIIC Cisplatin NA
6 45 Female 11.15*8.20*9.22 T3N1M0 High-grade Serous IIIC Cisplatin NA
7 53 Female 11*9.5 T3N1M1 High-grade Serous IIIC Taxol; Carboplatin NA
8 45 Female 8*5*1.2 T3N0M0 High-grade Serous IIIB Taxol; Carboplatin NA
9 44 Female 4*4*3 T3N1M1 High-grade Serous IVA Taxol; Carboplatin NA

NA, Not applicable.